Compound Detail
CHEMBL25
ASPIRIN 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL25 |
| Name | ASPIRIN |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | BSYNRYMUTXBXSQ-UHFFFAOYSA-N |
| Therapeutic | ✓ Yes |
22
Targets
213
Activities
3
Assay Types
30
PK Parameters
20
Publications
30
Known Names
20
Indications
1
Mechanisms
Molecular Properties
180.2
MW (Da)
1.31
ALogP
3
HBA
1
HBD
63.6
PSA (Ų)
0.55
QED
0
Ro5 Violations
2
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 1950 |
| Availability | OTC |
| Chirality | Achiral |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Cyclooxygenase inhibitor | INHIBITOR | Cyclooxygenase | ✓ | ✓ |
Indications
Arthritis Back Pain Common Cold Common Cold Coronary Artery Disease Dysmenorrhea Fever Headache Migraine Disorders Muscle Cramp Myalgia Myocardial Infarction Myocardial Infarction Pain Spasm Stroke Thrombosis Thrombosis Toothache Abortion, Habitual
ATC Classification
A01AD05
acetylsalicylic acid
Level 1: ALIMENTARY TRACT AND METABOLISM
Level 2: STOMATOLOGICAL PREPARATIONS
B01AC06
acetylsalicylic acid
Level 1: BLOOD AND BLOOD FORMING ORGANS
Level 2: ANTITHROMBOTIC AGENTS
N02BA01
acetylsalicylic acid
Level 1: NERVOUS SYSTEM
Level 2: ANALGESICS
N02BA51
acetylsalicylic acid, combinations excl. psycholeptics
Level 1: NERVOUS SYSTEM
Level 2: ANALGESICS
N02BA71
acetylsalicylic acid, combinations with psycholeptics
Level 1: NERVOUS SYSTEM
Level 2: ANALGESICS
Activity Summary
IC50 195 meas. best 8.49
Ki 14 meas. best 9.3
EC50 4 meas.
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Nicotinate phosphoribosyltransferase CHEMBL4523354 | Ki | 9.3 | 9.3 | 0.5 | 1 |
| NON-PROTEIN TARGET CHEMBL3879801 | IC50 | 8.49 | 4.9317 | 3.2 | 24 |
| Unchecked CHEMBL612545 | IC50 | 6.79 | 4.9375 | 162.0 | 12 |
| Prostaglandin G/H synthase 1 CHEMBL2949 | IC50 | 6.52 | 6.1563 | 300.0 | 27 |
| Prostaglandin G/H synthase 1 CHEMBL221 | IC50 | 6.46 | 5.31 | 350.0 | 5 |
| Prostaglandin G/H synthase 1 CHEMBL2860 | IC50 | 6.46 | 6.46 | 350.0 | 1 |
| Blood CHEMBL613444 | IC50 | 6.37 | 6.365 | 430.0 | 2 |
| Plasma CHEMBL613424 | IC50 | 5.96 | 5.96 | 1110.0 | 1 |
| Platelet CHEMBL4296519 | IC50 | 5.96 | 4.678 | 1110.0 | 10 |
| Prostaglandin G/H synthase 2 CHEMBL230 | IC50 | 5.62 | 5.2308 | 2400.0 | 12 |
| Prostaglandin G/H synthase 2 CHEMBL4102 | IC50 | 5.62 | 5.5741 | 2400.0 | 17 |
| Homo sapiens CHEMBL372 | IC50 | 5.35 | 4.3946 | 4500.0 | 13 |
| Integrin alpha-IIb/beta-3 CHEMBL2093869 | IC50 | 5.3 | 5.3 | 5000.0 | 1 |
| Cyclooxygenase CHEMBL2094253 | IC50 | 4.82 | 4.82 | 15000.0 | 1 |
| HCT-8 CHEMBL613510 | IC50 | 4.81 | 4.81 | 15600.0 | 1 |
| Oryctolagus cuniculus CHEMBL374 | IC50 | 4.8 | 4.72 | 16000.0 | 2 |
| Blood CHEMBL613615 | IC50 | 4.74 | 4.74 | 18400.0 | 1 |
| HaCaT CHEMBL614392 | IC50 | 4.67 | 4.67 | 21270.0 | 1 |
| Prostaglandin G/H synthase 1 CHEMBL2949 | Ki | 4.55 | 4.55 | 27900.0 | 1 |
| Glutathione hydrolase 1 proenzyme CHEMBL5696 | IC50 | 4.44 | 4.44 | 36000.0 | 1 |
| RAW264.7 CHEMBL612557 | IC50 | 4.37 | 4.37 | 43200.0 | 1 |
| Cavia porcellus CHEMBL369 | IC50 | 4.32 | 4.265 | 48000.0 | 2 |
| Prostaglandin G/H synthase 2 CHEMBL230 | Ki | 4.28 | 4.28 | 52000.0 | 1 |
| Plasma CHEMBL613652 | IC50 | 4.27 | 4.27 | 54000.0 | 1 |
| Prostaglandin G/H synthase 1 CHEMBL221 | Ki | 4.21 | 4.21 | 62000.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 4051000.0 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 909000.0 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 436800.0 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 89780.0 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 3516.67 | ng.hr.mL-1 | Homo sapiens |
| AUC | 3833.33 | ng.hr.mL-1 | Homo sapiens |
| AUC | 6883.33 | ng.hr.mL-1 | Homo sapiens |
| AUC | 7283.33 | ng.hr.mL-1 | Homo sapiens |
| CL | 12.0 | mL.min-1.kg-1 | Homo sapiens |
| CL | 12.0 | mL.min-1.kg-1 | Homo sapiens |
| Cmax | 14376.11 | nM | Homo sapiens |
| Cmax | 28308.17 | nM | Homo sapiens |
| Cmax | 48845.47 | nM | Homo sapiens |
| F | 79.0 | % | Homo sapiens |
| F | 68.0 | % | Homo sapiens |
| F | 100.0 | % | Homo sapiens |
| Fu | 0.68 | - | Homo sapiens |
| MRT | 0.3 | hr | Homo sapiens |
| T1/2 | 1.06 | hr | Homo sapiens |
| T1/2 | 2.0 | hr | Homo sapiens |
| T1/2 | 1.05 | hr | Homo sapiens |
| T1/2 | 9.8 | hr | Homo sapiens |
| T1/2 | 0.26 | hr | Homo sapiens |
| T1/2 | 1.05 | hr | Homo sapiens |
| T1/2 | 1.05 | hr | Homo sapiens |
| T1/2 | 0.5167 | hr | Homo sapiens |
| T1/2 | 0.9167 | hr | Homo sapiens |
| T1/2 | 0.25 | hr | Homo sapiens |
| T1/2 | 336.0 | hr | - |
| T1/2 | 17.46 | hr | - |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
Data from ChEMBL 36 via Core Engine